Home LiteratureArticle Details
PMID: 20006839 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.

Cell host & microbe ·Vol. 6 ·No. 6 ·2009-12-17 ·Pages 503-12

Perona-Wright G, Mohrs K, Szaba FM, Kummer LW, Madan R, Karp CL, Johnson LL, Smiley ST, Mohrs M

Abstract

Surviving infection represents a balance between the proinflammatory responses needed to eliminate the pathogen, and anti-inflammatory signals limiting damage to the host. IL-10 is a potent immunosuppressive cytokine whose impact is determined by the timing and localization of release. We show that NK cells rapidly express IL-10 during acute infection with diverse rapidly disseminating pathogens. The proinflammatory cytokine IL-12 was necessary and sufficient for NK cell induction of IL-10. NK cells from mice with systemic parasitic infection inhibited dendritic cell release of IL-12 in an IL-10-dependent manner, and NK cell depletion resulted in elevated serum IL-12. These data suggest an innate, negative feedback loop in which IL-12 limits its own production by eliciting IL-10 from NK cells. In contrast to disseminating pathogens, locally restricted infections did not elicit NK cell IL-10. Thus systemic infections uniquely engage NK cells in an IL-10-mediated immunoregulatory circuit that functions to alleviate inflammation.

MeSH Terms
Animals Cells, Cultured Gene Expression Immunosuppressive Agents/immunology Infections/immunology,microbiology,parasitology Interleukin-10/genetics,immunology Interleukin-12/genetics,immunology Killer Cells, Natural/immunology Listeria monocytogenes/immunology Mice Mice, Inbred C57BL Mice, Knockout Toxoplasma/immunology Yersinia pestis/immunology
Chemicals
Immunosuppressive Agents Interleukin-10 Interleukin-12
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Perona-Wright Georgia
Trudeau Institute, Saranac Lake, NY 12983, USA.
Mohrs Katja
Szaba Frank M
Kummer Lawrence W
Madan Rajat
Karp Christopher L
Johnson Lawrence L
Smiley Stephen T
Mohrs Markus
References (56)
56 references, click to expand
  1. IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease.
    Int Immunol. 2007 Sep;19(9):1123-34 PMID: 17660499
  2. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.
    Immunity. 2008 Aug 15;29(2):295-305 PMID: 18701085
  3. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function.
    J Exp Med. 2003 Oct 6;198(7):1069-76 PMID: 14530376
  4. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.
    J Immunol. 1994 Sep 15;153(6):2533-43 PMID: 7915739
  5. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii.
    J Immunol. 2000 May 15;164(10):5375-82 PMID: 10799901
  6. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.
    Nat Immunol. 2007 Dec;8(12):1363-71 PMID: 17994025
  7. The immunopathogenesis of sepsis.
    Nature. 2002 Dec 19-26;420(6917):885-91 PMID: 12490963
  8. IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites.
    J Immunol. 2000 Dec 1;165(11):6221-8 PMID: 11086056
  9. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection.
    J Exp Med. 2007 Feb 19;204(2):273-83 PMID: 17283209
  10. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
    J Infect Dis. 2003 May 1;187(9):1442-51 PMID: 12717626
  11. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.
    J Immunol. 1994 Feb 15;152(4):1883-7 PMID: 7907107
  12. CD8- dendritic cell activation status plays an integral role in influencing Th2 response development.
    J Immunol. 2001 Aug 15;167(4):1982-8 PMID: 11489979
  13. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.
    Nat Immunol. 2006 Nov;7(11):1217-24 PMID: 17013389
  14. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis.
    Infect Immun. 2005 Jul;73(7):3888-95 PMID: 15972474
  15. Natural killer cells and dendritic cells: rendezvous in abused tissues.
    Nat Rev Immunol. 2002 Dec;2(12):957-64 PMID: 12461568
  16. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production.
    J Exp Med. 2007 Oct 29;204(11):2591-602 PMID: 17923502
  17. Regulatory activity of autocrine IL-10 on dendritic cell functions.
    J Immunol. 2001 Apr 1;166(7):4312-8 PMID: 11254683
  18. Systemic dissemination and persistence of Th2 and type 2 cells in response to infection with a strictly enteric nematode parasite.
    J Immunol. 2005 Oct 15;175(8):5306-13 PMID: 16210636
  19. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis.
    J Immunol. 2008 May 1;180(9):6334-45 PMID: 18424757
  20. IL-10: the master regulator of immunity to infection.
    J Immunol. 2008 May 1;180(9):5771-7 PMID: 18424693
  21. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.
    Eur J Immunol. 2007 Feb;37(2):445-55 PMID: 17273991
  22. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.
    Nat Med. 2009 Mar;15(3):277-84 PMID: 19234462
  23. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12.
    J Immunol. 1998 Mar 15;160(6):2637-44 PMID: 9510161
  24. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Infect Immun. 2005 Nov;73(11):7304-10 PMID: 16239527
  25. Cytokine expression by murine DX5+ cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18.
    Cell Immunol. 2001 Aug 25;212(1):71-81 PMID: 11716531
  26. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages.
    J Immunol. 2004 Feb 1;172(3):1407-13 PMID: 14734716
  27. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.
    Immunity. 1996 May;4(5):471-81 PMID: 8630732
  28. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging.
    J Exp Med. 2006 Mar 20;203(3):619-31 PMID: 16505138
  29. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
    J Immunol. 1996 Jul 15;157(2):798-805 PMID: 8752931
  30. Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.
    Clin Cancer Res. 2003 Jan;9(1):76-83 PMID: 12538454
  31. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.
    Immunity. 2008 Apr;28(4):468-76 PMID: 18400189
  32. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.
    Nat Immunol. 2004 Dec;5(12):1260-5 PMID: 15531883
  33. Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells.
    Genes Immun. 2008 Jun;9(4):316-27 PMID: 18401353
  34. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.
    J Exp Med. 2007 Feb 19;204(2):285-97 PMID: 17283207
  35. Interleukin-10 and the interleukin-10 receptor.
    Annu Rev Immunol. 2001;19:683-765 PMID: 11244051
  36. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.
    Science. 1988 Apr 22;240(4851):516-8 PMID: 3128869
  37. The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-gamma production.
    J Immunol. 2005 Jun 15;174(12):7732-9 PMID: 15944275
  38. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.
    J Exp Med. 2004 Nov 15;200(10):1289-97 PMID: 15534372
  39. Depletion of NK cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response.
    Shock. 2008 Oct;30(4):401-10 PMID: 18391857
  40. NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway.
    J Immunol. 2007 Jul 1;179(1):590-6 PMID: 17579080
  41. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
    Blood. 1996 Jun 15;87(12):5144-51 PMID: 8652827
  42. Regulatory NK cells suppress antigen-specific T cell responses.
    J Immunol. 2008 Jan 15;180(2):850-7 PMID: 18178824
  43. Regulatory T cells and infection: a dangerous necessity.
    Nat Rev Immunol. 2007 Nov;7(11):875-88 PMID: 17948021
  44. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Nat Immunol. 2007 Sep;8(9):931-41 PMID: 17694059
  45. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.
    Immunity. 2006 Dec;25(6):941-52 PMID: 17137799
  46. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Infect Immun. 2007 Feb;75(2):878-85 PMID: 17118978
  47. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
    Blood. 2001 May 15;97(10):3146-51 PMID: 11342442
  48. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?
    Nat Immunol. 2001 Oct;2(10):917-24 PMID: 11577347
  49. Differentiation of human NK cells into NK1 and NK2 subsets.
    J Immunol. 1998 Dec 1;161(11):5821-4 PMID: 9834059
  50. Fibrin-mediated protection against infection-stimulated immunopathology.
    J Exp Med. 2003 Mar 17;197(6):801-6 PMID: 12629066
  51. B cells regulate autoimmunity by provision of IL-10.
    Nat Immunol. 2002 Oct;3(10):944-50 PMID: 12244307
  52. Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cells.
    Clin Exp Immunol. 1999 Sep;117(3):529-34 PMID: 10469058
  53. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.
    J Immunol. 2000 Feb 15;164(4):2009-15 PMID: 10657652
  54. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation.
    J Immunol. 2009 Aug 15;183(4):2312-20 PMID: 19620304
  55. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis.
    Am J Perinatol. 2008 Nov;25(10):629-36 PMID: 18850512
  56. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
    Nat Rev Immunol. 2005 Jul;5(7):521-31 PMID: 15999093
Article Info
Journal
Cell host & microbe
Abbr.
Cell Host Microbe
ISSN
1934-6069
Published
2009-12-17
Pages
503-12
Language
English
Region
United States
NLM ID
101302316
PMCID
PMC2796259
Subset
IM
Grants
NIAID NIH HHS · AI061577 · United States
NIAID NIH HHS · R01 AI057992 · United States
NIAID NIH HHS · R56 AI061577 · United States
NIAID NIH HHS · R01 AI061577 · United States
NIAID NIH HHS · R21 AI061587 · United States
NIAID NIH HHS · AI61587 · United States
NIAID NIH HHS · R01 AI072296 · United States
NIAID NIH HHS · AI072296 · United States
NIAID NIH HHS · R01 AI072296-03 · United States
NIAID NIH HHS · AI057992 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com